Growth Factor and Signaling Pathways and Their Relevance in Prostate Cancer Therapeutics
European Prostate Cancer Therapeutics Market “The European Market for Prostate Cancer Therapeutics...
5
European Prostate Cancer Therapeutics Market “The European Market for Prostate Cancer Therapeutics is largely underdeveloped. It is constantly changing, offering industry participants many new market opportunities.”
-
Upload
octavia-stewart -
Category
Documents
-
view
222 -
download
2
Transcript of European Prostate Cancer Therapeutics Market “The European Market for Prostate Cancer Therapeutics...
European Prostate Cancer Therapeutics Market
“The European Market for Prostate Cancer Therapeutics is largely underdeveloped. It is
constantly changing, offering industry participants many new market
opportunities.”
Key features
• Quality Analysis of the European LHRH and Anti-Androgen Therapeutics Market
• The most in depth Analysis available of the European Brachytherapy Seeds Market
• Coverage of Emerging Therapies• Strong Focus on Market Challenges & Strategies
VOICE OVER TIPS
• make sure the bullet points stand up on their own• raise the most salient points and talk knowledgably around
each one!• Target time 30 - 40 seconds
Key content: Revenue Forecasts & Competitive Analysis
Total Prostate Cancer Therapeutics Market: Revenue Forecasts (Europe), 1998 - 2008
0
200
400
600
800
1000
1200
1400
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
Year
Re
ve
nu
es ($m
)
Market Size and Forecast
Segmentation: LHRH Analogs, Anti-Androgens Brachytherapy Seeds
Market Share Analysis- European & Country Levels
Featured Companies
• AstraZeneca• Takeda• Ipsen Biotech• Schering Ag• Amersham Health
What to do next
For more informationCall 44 20 7343 8342 or
Prostate Cancer Therapeutics is part of the Global Oncology
Subscription www.pharma.frost.com
